Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Accueil  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Leonard Schleifer
Age : 66
Public asset : 1,253,927,693 USD
Country of residence : Unknown
Linked companies : Regeneron Pharmaceuticals, Inc.

Summary 
Leonard S. Schleifer founded Regeneron Pharmaceuticals, Inc. Currently, Dr. Schleifer is Co-President, Chief Executive Officer & Director at this company.

In the past Dr. Schleifer was Assistant Professor at Weill Cornell Medical College.

Dr. Schleifer received a doctorate from the University of Virginia.




Current positions of Leonard Schleifer 
Holdings of Leonard Schleifer 
Leonard Schleifer : Personal Network 
Most Read News 
11/17WARREN BUFFETT : Buffett's Berkshire bets on Big Pharma, invests in four drugmakers
RE
11/25THIERRY BRETON : EU's Breton
RE
11/28ELON MUSK : Tesla's Delayed Semi Truck Tests Elon Musk's Ability to Scale Up
DJ
11/27XAVIER NIEL : French tycoon Xavier Niel could launch SPAC company next week - sources
RE
11/17WILLIAM ACKMAN : As Ackman hunts blockbuster deal, he counts on big backers
RE
11/19MARY BARRA : GM's Barra accelerates 'all out pursuit of global EV leadership'
RE
11/17THEODOR WEIMER : Deutsche Boerse to buy 80% of ISS for $1.8 billion
RE
01:27aANTÓNIO HORTA-OSÓRIO : Credit Suisse to propose outgoing Lloyds Bank CEO as chairman
RE
11/19PETER THIEL : Peter Thiel joins board of antibody therapy developer AbCellera
RE
11/28PHILIP GREEN : Frasers Group offers emergency loan to Philip Green's troubled Arcadia Group - Sky
RE
More news


© 2020 People and Ownership :   
Leonard Schleifer : Connections 


Latest news about Leonard Schleifer 
11/21FDA Authorizes Regeneron's Covid-19 Antibody Cocktail Drug -- Update
DJ
11/05Regeneron hopes U.S. will authorize coronavirus antibody drug soon
RE
11/05REGENERON PHARMACEUTICALS : hopes U.S. will authorize coronavirus antibody drug soon
RE
08/23Antibody Drugs Advancing to Fill Covid-19 Treatment Gap
DJ
08/19REGENERON PHARMACEUTICALS : Roche, Regeneron link up to develop COVID-19 antibody cocktail
RE
08/19REGENERON PHARMACEUTICALS : Roche, Regeneron link up to develop COVID-19 antibody cocktail
RE
08/19REGENERON PHARMACEUTICALS : Enlists Swiss Rival Roche to Help Make Covid-19 Drug
DJ
More news


Popular Business Leaders 
Jean-paul Agon Mukesh Ambani Bernard Arnault Mary Barra Werner Baumann Jeff Bezos Leon Black Richard Branson Markus Braun Thierry Breton Warren Buffett Bertrand Camus Jean-pierre Clamadieu Tim Cook Jean-charles Decaux Elmar Degenhart Leonardo Del Vecchio Herbert Diess Jack Dorsey Patrick Drahi Nicandro Durante Sergio Ermotti Antoine Frérot Bill Gates Philip Green Ralph Hamers David Henry Carl Icahn Arnaud Lagardère Jack Ma Catherine Macgregor Rupert Murdoch Elon Musk Xavier Niel Michael O'leary Bernd Osterloh James Packer Patrick Pouyanné Alessandro Profumo Pedro Pullen Parente Alexandre Ricard Masayoshi Son Carsten Spohr Friede Springer Philippe Varin François Villeroy De Galhau Axel Weber Dieter Zetsche Mark Zuckerberg Luca De Meo
A-Z Business Leaders